
Address
ProtAffin Biotechnologie AG
50-13 Cheongdam-Dong
4F, Sang Min Building Kangnam-Gu
Seoul
135-100
South Korea
Website
VCID: 124025
Profile
Corporate information
Official name
ProtAffin Biotechnologie AG
Registration country
Investment activity status
Active investor
Company type
A biotechnology company developing a novel class of biopharmaceuticals based on glycan-binding decoy proteins.Funding
Funding rounds
(1 Apr 2009)
Investor | Profile | Country | Notes | |
---|---|---|---|---|
![]() |
Atlas Venture | Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US. | United States | 14,100,000 Initial investment. Round participant. |
Cap Table
Current and past shareholders
Investor | Round | |
---|---|---|
![]() |
Atlas Venture Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US. |
Series B |